Daily summary: Global markets start the week on a positive note

6:12 PM 13 July 2020
• Earnings season has begun
• Nasdaq hits new high
• Pfizer (PFE.US)and BioNTech (BNTX.US) granted FDA fast track designation for two Covid-19 vaccine candidates

European inidices finished today’s session higher as investors cheered signs of progress in COVID-19 vaccine development after two possible Covid-19 vaccines from Pfizer and BioNTech granted FDA fast track designation. DAX finished 1.3% higher, CAC 40 rose 1.7% and FTSE 100 gained 1.3%.

US indices rose on Monday with Nasdaq hitting a new high, helped by a better than expected quarterly results from Pepsi Co (PEP.US), as well as signs of progress in COVID-19 vaccine development. These news completely overshadowed surging numbers of new COVID-19 cases. Coronavirus infections rose above 13 million across the world on Monday, climbing by one million in just five days. World Health Organization chief Tedros Adhanom Ghebreyesus said there would be no return to the old normal for the foreseeable future, with too many countries headed in the wrong direction. "The virus remains public enemy number one," he told a virtual briefing from WHO headquarters in Geneva. "If basics are not followed, the only way this pandemic is going to go, it is going to get worse and worse and worse. But it does not have to be this way." he said. On Sunday World Health Organization recorded record 230,000 of new confirmed COVID-19 cases, while Florida reported a record increase of more than 15,000 infections.
However it seems that,  investors pay little attention to these numbers and focus on the second-quarter earnings season which started this week. Markets are expecting the sharpest drop in quarterly earnings for S&P 500 firms since the last financial crisis. Upcoming data will reveal the extent of the damage wreaked by coronavirus-induced lockdowns on corporate profits. This week investors are looking forward for updates  from health care companies such as Johnson & Johnson and Abbott, banking giants including JPMorgan Chase, Wells Fargo, Goldman Sachs, Citigroup and Bank of America, and streaming video-on-demand service Netflix. At the same time, traders looked to the release of key economic data such as US consumer inflation, retail sales and industrial output figures for June, as well as China's second quarter GDP and trade data. During today’s session Dow Jones rose 1.61% S&P500 added 1.3% and Nasdaq I s trading 1.7% higher.

Gold and silver are trading higher, with silver prices scoring an 11-month high and closing in on $20/oz resistance level. Meanwhile gold prices rose above the key $1,800/oz  level. Buying interest continues to be fueled by ongoing U.S.-China trade tensions and the record number of new COVID-19 cases. Despite hopes of a vaccine-breakthrough, many investors remain concerned that the recovery of the global economy may take longer than originally assumed.

Oil prices managed to erase early losses as investors await OPEC technical meeting this week, which is expected to recommend an easing in output cuts. Both WTI and Brent are trading flat.

There is quite a lot of data scheduled for release tomorrow. During the Asian session investors will get to know trade data from China and Japanese industrial production figures. GDP data from the UK, German  ZEW Economic Sentiment Index and inflation figures will be the key releases of the European session. Apart from that Consumer Price Index figures will be published in the afternoon. Last but not least, FED Kaplan and Williams are scheduled to speak. Oil Traders will be looking at API inventory numbers. On the earnings front  JPMorgan Chase, Wells Fargo,  Citigroup Inc, Continental AG, Delta Airlines will publish their quarterly results.
GBPUSD  - price  again bounced off the 200 MA (redline), signaling that bears are in control of the market. Should downbeat moods prevail, support at 1.2480 may come into play. On the other hand, breaking above the 1.2676 handle may lead to a bigger upward move. Source: xStation5
Share:
Back

Join over 1 600 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits